Decreased serum inhibin B/FSH ratio as a marker of sertoli cell function in male survivors after chemotherapy in childhood and adolescence

Journal of Pediatric Endocrinology and Metabolism

Volumn 17, Issue 6, 2004, Pages 879-887

  Neves Bordallo, Maria Alice ^a,b,d   Guimarães, Marília Martins ^c   Pessoa, Cencita Hosanha C N ^a   Carriço, Maria Kadma ^a   Dimetz, Trude ^b   Gazolla, Helena Mussi ^b   Dobbin, Jane ^a   Castilho, Ilda Akemi Muramoto Alves ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d NONE   (Brazil)

Author keywords

C MOPP ABV hybrid program; Chemotherapy; Hodgkin's disease; Inhibin B; Long term survivors of childhood cancer; Male gonadal function; Semen analysis; Sertoli cell

Indexed keywords

BIOLOGICAL MARKER; BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FOLLITROPIN; INHIBIN B; LUTEINIZING HORMONE; PREDNISONE; PROCARBAZINE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; VINBLASTINE; VINCRISTINE;

ADOLESCENCE; ADOLESCENT; ARTICLE; AZOOSPERMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CELL FUNCTION; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG CYTOTOXICITY; DRUG DOSE REGIMEN; FOLLITROPIN BLOOD LEVEL; GONAD DYSFUNCTION; HODGKIN DISEASE; HORMONE BLOOD LEVEL; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MALE; OLIGOSPERMIA; SEMEN ANALYSIS; SERTOLI CELL; STATISTICAL SIGNIFICANCE; TESTIS DISEASE; TESTIS SIZE; TESTOSTERONE BLOOD LEVEL;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; FOLLICLE STIMULATING HORMONE; HODGKIN DISEASE; HUMANS; INHIBINS; MALE; OLIGOSPERMIA; ORGAN SIZE; PREDNISONE; PROCARBAZINE; SERTOLI CELLS; SPERM COUNT; SURVIVAL ANALYSIS; TESTIS; VINCRISTINE;

EID: 3242887944     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Anawalt BD, Bebb RA, Matsumoto AM, Groome NP, Illingworth PJ, McNeilly AS, Bremner WJ. Serum inhibin B levels reflect Sertoli cell function in normal men with testicular dysfunction. J Clin Endocrinol Metab 1996; 81: 3341-3345.
2. Wallace EM, Groome NP, Riley SC, Parker AC, Wu FC. Effects of chemotherapy-induced testicular damage on inhibin, gonadotropin, and testosterone secretion: a prospective longitudinal study. J Clin Endocrinol Metab 1997; 82: 3111-3115.
3. Dhabhar BN, Malhotra H, Joseph R, Gades S, Bhasin S, Sheth A, Advani SH. Gonadal function in prepubertal boys following treatment for Hodgkin's disease. Am J Pediatr Hematol Oncol 1993; 15: 306-310.
4. Robertson DM, Tsonis CG, McLachlan RI, Handelsman DJ, Leask R, Baird DT, McNeilly AS, Hayward S, Healy DL, Findlay JK. Comparison of inhibin immunological and in vitro biological activities in human serum. J Clin Endocrinol Metab 1988; 67: 438-443.
5. von-Eckardstein S, Simoni M, Bergmann M, Weinbauer GF, Gassner P, Schepers AG. Serum inhibin B in combination with serum follicle-stimulating hormone (FSH) is a more sensitive marker than serum FSH alone for impaired spermatogenesis in men, but cannot predict the presence of sperm in testicular tissue samples. J Clin Endocrinol Metab 1999; 84: 2496-2501.
6. Mackie EJ, Radford M, Shalet SM. Gonadal function following chemotherapy for childhood Hodgkin's disease. Med Pediatr Oncol 1996; 27: 74-78.
7. Klingmuller D, Haidl G. Inhibin B in men with normal and disturbed spermatogenesis. Hum Reprod 1997; 12: 2376-2378.
8. Matus-Ridley M, Nicosia SV, Meadows AT. Gonadal effects of cancer therapy in boys. Cancer 1985; 55: 2353-2363.
9. Rosen SW, Weintraub BD. Monotropic increase of serum FSH correlated with low sperm count in young men with idiopathic oligospermia and aspermia. J Clin Endocrinol Metab 1971; 32: 410-416.
10. Franchimont P, Millet D, Vendrely E, Letawe J, Legros JJ, Netter A. Relationship between spermatogenesis and serum gonadotropin levels in azoospermia and oligospermia. J Clin Endocrinol Metab 1972; 34: 1003-1008.
11. Bergmann M, Behre HM, Nieschlag E. Serum FSH and testicular morphology in male infertility. Clin Endocrinol (Oxf) 1994; 40: 133-136.
12. Brugo-Olmedo S, De Vicents S, Calamera JC, Urrutia F, Nodar F, Acosta AA. Serum inhibin B may be a reliable marker of the presence of testicular spermatozoa in patients with nonobstructive azoospermia. Fertil Steril 2001; 76: 1124-1129.
13. Jensen TK, Andersson AM, Hyollund NHI, Sheike T, Kolstad H, Giwercman A, Henriksen TB, Ernst E, Bonde JP, Olsen J, McNeilly A, Groome NP, Skakkebaek NE. Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle stimulating hormone levels. A study of 349 Danish men. J Clin Endocrinol Metab 1997; 82: 4059-4063.
14. Sherins JR, Olweny LMC, Ziegler JL. Gynecomastia and gonadal dysfunction in adolescent boys treated with combination chemotherapy for Hodgkin's disease. N Engl J Med 1978; 299: 12-16.
15. Relander T, Cavallin-Stahl EC, Garwicz S, Olsson AM. Gonadal and sexual function in men treated for childhood cancer. Med Pediatr Oncol 2000; 35: 52-63.
16. Papadakis V, Vlachopapadopoulou E, Van Syckle K. Gonadal function in young patients treated for Hodgkin's disease. Med Pediatr Oncol 1999; 32: 366-372.
17. Mustieles C, Munõz A, Alonso M, Ros P, Yturriaga R, Maldonado S, Otheo E, Barrio R. Male gonadal function after chemotherapy in survivors of childhood malignancy. Med Pediatr Oncol 1995; 24: 347-351.
18. Petersen PM, Andersson AM, Roth M, Laugcard G, Skakkebaek NE. Undetectable inhibin B serum levels in men after testicular irradiation. J Clin Endocrinol Metab 1999; 84: 213-215.
19. Latheenmaki PM, Toppari J, Ruokonen A, Laitinen P, Salmi TT. Low serum inhibin B concentrations in male survivors of childhood malignancy. Eur J Cancer 1999; 35: 612-619.
20. Cicognani A, Cacciari E, Pasini A, Burnelli R, De Iasio R, Pirazzoli P, Paolucci G. Low serum inhibin B levels as a marker of testicular damage after treatment for a childhood malignancy. Eur J Pediatr 2000; 159: 103-107.
21. Chatterjee R, Mills W, Katz M, McGarrigle HH, Goldstone AH. Germ cell failure and Leydig cell insufficiency in pos-pubertal males after autologous bone marrow transplantation with BEAM for lymphoma. Bone Marrow Transplant 1994; 13: 519-522.
22. Siimes MA, Rautonen J. Small testicles with impaired production of sperm in adult male survivors of childhood malignancies. Cancer 1990; 65: 1303-1306.
23. Tsatsoulis A, Shalet SM, Morris ID, Krestser DM. Immunoactive inhibin as a marker of Sertoli cell function following cytotoxic damage to the human testis. Horm Res 1990; 34: 254-259.
24. Sy Ortin TT, Shostak CA, Donaldson SS. Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience. Int J Radiat Oncol Biol Phys 1990; 19: 873-880.
25. Shafford EA, Kingtons JE, Malpas JS, Plowman PN, Pritchard J, Savage MO, Eden OB. Testicular function following the treatment of Hodgkin's disease in childhood. Br J Cancer 1993; 68: 1199-1204.
26. Bordallo MAN, Mello RC, Tabak D. Gonadal status after bone marrow transplantation (BMT) in childhood. Horm Res 1998; 50: 114.
27. Chan PT, Palermo GD, Veeck LL, Rosenwarks Z, Schlegel PN. Testicular sperm extraction combined with intracytoplasmic sperm injection in the treatment of men with persistent azoospermia postchemotherapy. Cancer 2001; 92: 1632-1637.
28. Anderson AM, Muller J, Groome NP, Skakkebaek NE. Serum inhibin B levels in prepubertal boys are germ cell independent. Horm Res 1998, 50: 12 (Abst).
29. Frydelund-Larsen L, Krausz C, Leffers H, Andersson AM, Carlsen E, Bangsboell S, McElreavey K, Skakkebaek NE, Raypert-De Meyts E. Inhibin B: a marker for the functional state of the seminiferous epithelium in patients with azoospermia factor C microdeletions. J Clin Endocrinol Metab 2002; 87: 5618-5624.
30. Damani MN, Masters V, Meng MV, Burgess C, Tureck P, Oates RD, Masters V. Postchemotherapy ejaculatory azoospermia: fatherhood with sperm from testis tissue with intracytoplasmic sperm injection. J Clin Oncol 2002; 20: 930-936.